Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.36 |
| ▸ | TGM2 | P21980 | 4/20 | 0.32 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
| ▸ | F13A1 | P00488 | 1/20 | 0.30 |
| ▸ | TGM1 | P22735 | 1/20 | 0.30 |
| ▸ | TGM3 | Q08188 | 1/20 | 0.30 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.30 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL168192 | 0.89 | — | — | |
| Hydrochloric Acid SCHEMBL27812565 | 0.86 | — | — | |
| Water SCHEMBL28045867 | 0.86 | — | — | |
| Bromide SCHEMBL28449390 | 0.86 | — | — | |
| Hydrochloric Acid SCHEMBL11660494 | 0.86 | — | — | |
| Acrylic Acid SCHEMBL9953445 | 0.81 | LMNA (0.56) | TSHRALDH1A1MAPK1TDP1FGFR4 | |
| Acrylamide SCHEMBL27937634 | 0.81 | TSHR (0.61) | TSHRALDH1A1MAPK1TDP1FGFR4 | |
| Oxalic Acid SCHEMBL10889014 | 0.79 | TSHR (0.40) | TSHRALDH1A1MAPK1TDP1FGFR4 | |
| Acrylamide SCHEMBL8606934 | 0.78 | — | — | |
| Glutaral SCHEMBL10558842 | 0.77 | HIF1A (0.43) | TSHRALDH1A1MAPK1TDP1FGFR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116925507-A | Heat-resistant thermoplastic polyester composition and preparation method thereof | 江苏康辉新材料科技有限公司 | 2023-10-24 | — | — | CN | claimed |
| CN-116925508-A | Heat-resistant degradable polyester composition and preparation method thereof | 江苏康辉新材料科技有限公司 | 2023-10-24 | — | — | CN | claimed |
| CN-116904005-A | Polylactic acid nucleating agent, heat-resistant polylactic acid composition and preparation method thereof | 大连理工大学 | 2023-10-20 | — | — | CN | claimed |
| CN-116694052-A | Furanyl polyester composition with high crystallization property and preparation method thereof | 大连理工大学 | 2023-09-05 | — | — | CN | claimed |
| CN-116640428-A | Polyester nucleating agent and preparation method thereof | 大连理工大学 | 2023-08-25 | — | — | CN | claimed |
| EP-4146744-A1 | HETERO-FUNCTIONAL COATING FOR CONJUGATING BIOMOLECULES ON A SOLID SUPPORT AND USE THEREOF FOR BIOANALYSIS | Waters Technologies Corporation (US) | 2023-03-15 | — | — | EP | claimed |
| CN-115551956-A | Heterofunctional coating for conjugating biomolecules on solid supports and use thereof for bioanalysis | 沃特世科技公司 | 2022-12-30 | — | — | CN | claimed |
| CN-115353647-A | Self-repairing marine-source collagen peptide-based composite hydrogel and preparation method thereof | 中国石油大学(华东) | 2022-11-18 | — | — | CN | claimed |
| WO-2021224887-A1 | HETERO-FUNCTIONAL COATING FOR CONJUGATING BIOMOLECULES ON A SOLID SUPPORT AND USE THEREOF FOR BIOANALYSIS | WATERS TECHNOLOGIES CORPORATION (US) | 2021-11-11 | — | — | WO | claimed |
| EP-1590373-B1 | CONJUGATES OBTAINED BY REDUCTIVE AMINATION OF SEROTYPE 5 PNEUMOCOCCUS CAPSULAR POLYSACCHARIDE | SANOFI PASTEUR (FR) | 2011-08-17 | — | — | EP | claimed |
| EP-1590373-A1 | CONJUGATES OBTAINED BY REDUCTIVE AMINATION OF SEROTYPE 5 PNEUMOCOCCUS CAPSULAR POLYSACCHARIDE | Sanofi Pasteur (FR) | 2005-11-02 | — | — | EP | claimed |
| US-20040170638-A1 | Conjugates obtained by reductive amination of the pneumococcus serotype 5 capsular polysaccharide | AVENTIS PASTEUR, S.A. | 2004-09-02 | — | — | US | claimed |
| WO-2004067574-A1 | CONJUGATES OBTAINED BY REDUCTIVE AMINATION OF SEROTYPE 5 PNEUMOCOCCUS CAPSULAR POLYSACCHARIDE | SANOFI PASTEUR (FR) | 2004-08-12 | — | — | WO | claimed |
| EP-1363672-A1 | CARRIER SYSTEMS COMPRISING VITAMIN B12 - BIODEGRADABLE MICRO PARTICULATE CONJU GATES FOR PERORAL DELIVERY OF DRUGS, PEPTIDES/PROTEINS AND VACCINES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH; An Indian Registered Body Incorporated Under The Registration of Societies Act; (IN) | 2003-11-26 | — | — | EP | claimed |
| US-20020192235-A1 | NOVEL VITAMIN B12 - BIODEGRADABLE MICRO PARTICULATE CONJUGATE CARRIER SYSTEMS FOR PERORAL DELIVERY OF DRUGS, THERAPEUTIC PEPTIDES/PROTEINS AND VACCINES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2002-12-19 | — | — | US | claimed |
| US-6482413-B1 | Vitamin B12 —biodegradable micro particulate conjugate carrier systems for peroral delivery of drugs, therapeutic peptides/proteins and vaccines | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2002-11-19 | — | — | US | claimed |
| WO-2002067995-A1 | CARRIER SYSTEMS COMPRISING VITAMIN B12 - BIODEGRADABLE MICRO PARTICULATE CONJU GATES FOR PERORAL DELIVERY OF DRUGS, PEPTIDES/PROTEINS AND VACCINES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2002-09-06 | — | — | WO | claimed |
| EP-0491501-B1 | The use of hydrazide stabilizers for 3-isothiazolones | ROHM & HAAS (US) | 1996-07-10 | — | — | EP | claimed |
| EP-0491501-A1 | The use of hydrazide stabilizers for 3-isothiazolones | ROHM AND HAAS COMPANY (US) | 1992-06-24 | — | — | EP | claimed |
| US-5118699-A | Microbiocides | ROHM AND HAAS COMPANY (US) | 1992-06-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040170638-A1 | Conjugates obtained by reductive amination of the pneumococcus serotype 5 capsular polysaccharide | FUT5, B3GNT2, CSGALNACT1 | TSHR 3909/4885ALDH1A1 2038/4885MAPK1 3563/4885 |
| US-20020192235-A1 | NOVEL VITAMIN B12 - BIODEGRADABLE MICRO PARTICULATE CONJUGATE CARRIER SYSTEMS FOR PERORAL DELIVERY OF DRUGS, THERAPEUTIC PEPTIDES/PROTEINS AND VACCINES | FOLR2, MMAB, VNN1 | TSHR 219/4885ALDH1A1 4813/4885MAPK1 4661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.